… Combination chemotherapy, generally platinum-based plus etoposide or irinotecan, is the
mainstay first-line treatment for metastatic small-cell lung cancer. For non-metastatic disease, …

… Depending on the staging of lung cancer, patients are eligible for certain treatments ranging
from … subtypes of lung cancer, small-cell lung carcinoma and non-small-cell lung carcinoma (…

… , lung cancer is the most common cause of cancer-related deaths. Molecular targeted therapies
and immunotherapies for non-small-cell lung cancer … to current treatments and eventually …

… Small-cell lung carcinoma is an aggressive form of lung cancer that … Limited-stage disease
should be treated with etoposide and … of growth when some cell lines are treated with imatinib. …

… -small cell lung cancer (NSCLC) is the leading cause of cancer-… cell carcinoma,
adenocarcinoma and large cell carcinoma, its represents approximately 80% to 85% of all lung …

… lung cancer there have been advances in many aspects of the classification, diagnosis, and
treatment of non-small-cell lung cancer … and more effective treatment of the disease, and the …

… Drugs approved by the FDA for the treatment of non-small-cell lung cancer. ALK, anaplastic
lymphoma kinase; EGFR, epidermal growth factor receptor; TKIs, tyrosine kinase inhibitors; …

… cell lung cancer accounts for 85% of all lung cancer cases in the United States. After the
initial diagnosis, accurate staging of non-small cell lung cancer … with lung cancer present with …

… Although clinical progress in SCLC treatment has been notoriously slow, a better … The
recent introduction of immune checkpoint blockade into the treatment of patients with SCLC is …

… Limited-stage small cell lung cancer (SCLC) is treated with concurrent chemoradiotherapy
with curative intent. Chemotherapy can prolong survival in patients with extensive-stage SCLC…